OSTEOPORE LIMITED — AGM Information 2022

Apr 6, 2022

==> picture [130 x 44] intentionally omitted <==

ASX RELEASE│OSTEOPORE LIMITED

Annual General Meeting Date

7 April 2022: Osteopore Limited (ASX: OSX) (“ Osteopore ” or “ the Company ”), advises, in accordance with ASX Listing Rule 3.13.1, that its Annual General Meeting will be held on Tuesday, 31 May 2022. The Company will follow the measures in place as set by the Australian and West Australian governments for the restriction of gatherings and the implementation of social distancing requirements in response to COVID-19.

An item of business at the AGM will be the re-election and appointment of directors. In accordance with clause 7.5 of the Company’s Constitution, the closing date for the receipt of nominations from persons wishing to be considered for election as a director is Wednesday, 13 April 2022.

Any nominations must be received at the Company’s registered office no later than 5:00pm (WST) on Wednesday, 13 April 2022.

This announcement has been approved for release by the Company Secretary of Osteopore.

For more information, please contact:

Deborah Ho

Company Secretary Osteopore Limited +61 8 9480 0500

About Osteopore Limited

Osteopore Ltd is an Australian and Singapore based medical technology company commercialising a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. Osteopore's patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.

Osteopore's patent-protected scaffolds are made from proprietary polymer formulations, that naturally dissolve over time to leave only natural, healthy bone tissue, significantly reducing postsurgery complications commonly associated with permanent bone implants.

Osteopore Limited (ACN 630 538 957)│ASX:OSX│16 Ord Street, West Perth│+618 9482 0500│www.osteopore.com

info@clearvuepv.com www.clearvuepv.com

West Perth WA 6872